Mandate

Vinge advises O2 in connection with its application for listing on NASDAQ OMX Stockholm

March 09, 2010

Vinge is advising the wind power company OM Vind AB in connection with the company’s application for listing on NASDAQ OMX Stockholm. The expected first day of trading is 22 March 2010. A new issue of not less than MSEK 950 and not more than MSEK 1,150 will be performed in conjunction with the listing. SEB Enskilda and Swedbank Markets are Joint Lead Managers and Book Runners in the offering. Vinge is also advising on the restructuring of O2’s legal structure which will take place prior to O2’s shares being admitted to trading. Vinge has also advised O2 in connection with negotiation of loan agreements in the amount of approximately SEK 2.4 billion with a Nordic bank consortium consisting of DnB Nor, SEB and Swedbank.

Vinge’s team primarily consists of Lena Almefelt, Petter Alberts, Fredrik Stjernström, Helena Backlund, Christian Johansson, Johan Cederblad, Kimmie Johansson and Andreas Wirén. As regards the loan financing aspect of the transaction, Vinge’s team primarily consists of Mikael Ståhl, Christian Johansson and Ulrica Åkesson.

Related

Vinge advises Atria Sverige in conjunction with an investment in Cookin Food

Atria Sverige has acquired a 25 per cent stake in the Swedish convenience food company Cookin Food Sweden AB. The transaction has been performed through the acquisition of shares in Bite Delight AB, which owns Cookin Food Sweden AB. Atria holds an option to acquire the remaining shares in Bite Delight AB after 2028.
March 04, 2026

Vinge advises Revivo Group on the acquisition of Solidenergy

Revivo Group, a portfolio company of Helix Kapital, has acquired Solidenergy, a leading provider of surface treatment services in the Norwegian market. The company operates within the energy, offshore and infrastructure sectors and is headquartered in Ågotnes outside Bergen. Solidenergy employs approximately 600 people.
March 03, 2026

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a partially guaranteed rights issue which is expected to provide Oncopeptides with proceeds of approximately SEK 200 million before deduction of transaction costs.
March 03, 2026